| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $652K | +86.3% |
| R&D Expense | $38.8M | -4.4% |
| SG&A Expense | $14.9M | +28.5% |
| Operating Income | -$53.1M | -2.3% |
| Income Tax | $0 | — |
| Net Income | -$51.8M | -5.1% |
| EPS (Basic) | -$11.04 | +91.2% |
| EPS (Diluted) | -$11.04 | +91.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64.0M | +66.9% |
| Current Assets | $66.4M | +65.9% |
| Total Assets | $78.3M | +42.5% |
| Current Liabilities | $9.6M | +22.9% |
| Total Liabilities | $15.2M | -8.3% |
| Stockholders' Equity | $63.1M | +151.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.6M | -3.2% |
| Capital Expenditures | $441K | -35.0% |
| Investing Cash Flow | -$441K | +35.0% |
| Financing Cash Flow | $71.7M | — |
| Free Cash Flow | -$46.0M | -2.6% |